Browse By Oncolytic Virus Species Result Page of OvirusTdb

The Total number of records shown on this page is 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_1530ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1531ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.01+/- 0.003, 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75 % cell death at CI 0.126NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1532ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.83+/- 0.61, 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell75 % cell death at CI 0.117NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1533ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.02+/- 0.01, 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell75 % cell death at CI 0.249NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1534ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell75 % cell death at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1535ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (17.69+/- 10.16, 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell75 % cell death at CI 0.030NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1536ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell75 % cell death at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1537ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.01+/- 0.003, 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.126NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1538ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.83+/- 0.61, 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.047NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1539ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.02+/- 0.01, 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.285NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1540ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1541ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (17.69+/- 10.16, 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.008NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1542ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1543ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.01+/- 0.003, 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.006NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1544ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.83+/- 0.61, 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.099NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1545ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.02+/- 0.01, 1:200)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.207NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1546ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1547ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (17.69+/- 10.16, 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.057NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1548ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1549ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.01+/- 0.003, 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.017NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1550ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.83+/- 0.61, 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.110NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1551ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.02+/- 0.01, 1:200)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.092NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1552ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1553ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (17.69+/- 10.16, 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.007NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1554ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1555ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.01+/- 0.003, 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.054NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1556ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.83+/- 0.61, 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.127NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1557ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.02+/- 0.01, 1:200)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.369NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1558ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1559ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (17.69+/- 10.16, 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.001NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1560ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1561ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(0.92+/-0.35nm, 1:5.3)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.255NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1562ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(48.40+/-23.08, 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 1.749NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1563ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(1.49+/-1.09nm, 1:2)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.316NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1564ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 3.275NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1565ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(28.46+/-14.13, 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.081NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1566ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1567ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(0.92+/-0.35nm, 1:5.3)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.149NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1568ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(48.40+/-23.08, 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 7.049NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1569ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(1.49+/-1.09nm, 1:2)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.056NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1570ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 1.927NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1571ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(28.46+/-14.13, 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.043NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1572ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1573ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(0.92+/-0.35nm, 1:5.3)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.089NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1574ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(48.40+/-23.08, 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1575ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(1.49+/-1.09nm, 1:2)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.019NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1576ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 1.134NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1577ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(28.46+/-14.13, 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.023NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1578ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1579ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(0.92+/-0.35nm, 1:53.3)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.069NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1580ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(48.40+/-23.08, 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.133NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1581ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(1.49+/-1.09nm, 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.367NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1582ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.193NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1583ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(28.46+/-14.13, 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.027NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1584ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1585ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(0.92+/-0.35nm, 1:53.3)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.045NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1586ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(48.40+/-23.08, 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 1.256NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1587ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(1.49+/-1.09nm, 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.052NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1588ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.651NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1589ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(28.46+/-14.13, 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.006NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1590ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1591ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(0.92+/-0.35nm, 1:53.3)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.031NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1592ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(48.40+/-23.08, 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 11.922NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1593ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(1.49+/-1.09nm, 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.008NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1594ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 2.192NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1595ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(28.46+/-14.13, 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.001NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1596ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1941ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoATCCHuman glioma cell lineU87NANAMTT assay0.0005 MOI100% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1943ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with NDVNoATCCHuman glioma cell lineU87NANAMTT assay0.0005 MOI100% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1944ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with parovirusNoATCCHuman glioma cell lineU87NANAMTT assay0.0005 MOI100% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1947ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoATCCHuman glioma cell lineU87NANAMTT assay0.005 MOI95% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1949ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with NDVNoATCCHuman glioma cell lineU87NANAMTT assay0.005 MOI90% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1950ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with parovirusNoATCCHuman glioma cell lineU87NANAMTT assay0.005 MOI100% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1953ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoATCCHuman glioma cell lineU87NANAMTT assay0.05 MOI90% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1955ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with NDVNoATCCHuman glioma cell lineU87NANAMTT assay0.05 MOI30% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1956ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with parovirusNoATCCHuman glioma cell lineU87NANAMTT assay0.05 MOI95% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1959ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoATCCHuman glioma cell lineU87NANAMTT assay0.5 MOI50% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1961Reoviruswild typeRNAReoviridaeNoneNoReovirus in combination with NDVNoATCCHuman glioma cell lineU87NANAMTT assay0.5 MOI10% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1962ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with parovirusNoATCCHuman glioma cell lineU87NANAMTT assay0.5 MOI50% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1965ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoATCCHuman glioma cell lineU87NANAMTT assay2.5 MOI30% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1967ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with NDVNoATCCHuman glioma cell lineU87NANAMTT assay2.5 MOI2% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1968ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with parovirusNoATCCHuman glioma cell lineU87NANAMTT assay2.5 MOI50% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1970ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoATCCHuman glioma cell lineU87NANAMTT assay5 MOI18% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1972ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with NDVNoATCCHuman glioma cell lineU87NANAMTT assay5 MOI2% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1973ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with parovirusNoATCCHuman glioma cell lineU87NANAMTT assay5 MOI2% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1976ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoATCCHuman glioma cell lineU373NANAMTT assay0.0005 MOI100% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1978ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with NDVNoATCCHuman glioma cell lineU373NANAMTT assay0.0005 MOI100% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1979ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with parovirusNoATCCHuman glioma cell lineU373NANAMTT assay0.0005 MOI100% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1982ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoATCCHuman glioma cell lineU373NANAMTT assay0.005 MOI97% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1984ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with NDVNoATCCHuman glioma cell lineU373NANAMTT assay0.005 MOI80% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1985ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with parovirusNoATCCHuman glioma cell lineU373NANAMTT assay0.005 MOI90% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1988ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoATCCHuman glioma cell lineU373NANAMTT assay0.05 MOI80% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1990ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with NDVNoATCCHuman glioma cell lineU373NANAMTT assay0.05 MOI45% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1991ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with parovirusNoATCCHuman glioma cell lineU373NANAMTT assay0.05 MOI50% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1994ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoATCCHuman glioma cell lineU373NANAMTT assay0.5 MOI70% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1996ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with NDVNoATCCHuman glioma cell lineU373NANAMTT assay0.5 MOI30% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_1997ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with parovirusNoATCCHuman glioma cell lineU373NANAMTT assay0.5 MOI30% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_2000ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoATCCHuman glioma cell lineU373NANAMTT assay2.5 MOI60% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_2002ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with NDVNoATCCHuman glioma cell lineU373NANAMTT assay2.5 MOI18% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667
OV_2003ReovirusReovirus T3DRNAReoviridaeNoneNoReovirus in combination with parovirusNoATCCHuman glioma cell lineU373NANAMTT assay2.5 MOI20% cell survivalNoNoNA No responseNAVirus alone and in combination enhance apoptosisNANA21607667